Alternatives to Mammoth Biosciences
Mammoth Biosciences is a Biotechnology tool: biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. Here are the 50 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Mammoth Biosciences
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Editas MedicineNot ratedA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- SYSynthetic Biology EngineeringNot rated
Engineering custom biological systems for various applications.
Integra TherapeuticsNot ratedBiotech company developing next-generation gene writing tools for advanced therapies.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
VizgenNot ratedSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
QuartzyNot ratedA vertically-integrated procurement platform for the life sciences industry.
Adaptyv BiosystemsNot ratedAutomated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
Immitra BioNot ratedScalable, one-time curative in-vivo gene editing therapies.
Houdini BioNot ratedEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Network BioNot ratedLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Showing the next 20 closest matches. See the rest on the Mammoth Biosciences profile.
Sponsored rows are paid and labelled. Advertise on this page
